Medicare Launches Pilot Program to Provide Free CBD to Seniors
New Federal Initiative Targets Symptom Management The Trump administration has launched a formal test program authorizing select Medicare patients to receive cannabidiol (CBD) at no cost. This initiative, rolling out across designated regions this year, seeks to evaluate whether the non-psychoactive cannabis compound can effectively manage chronic symptoms in older populations while simultaneously reducing overall…